Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Ann Intern Med. 2010 Mar 2;152(5):276-86. doi: 10.7326/0003-4819-152-5-201003020-00005.

Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes.

Author information

  • 1Stanford University, California 94305, USA.

Abstract

BACKGROUND:

Inclusion of 12-lead electrocardiography (ECG) in preparticipation screening of young athletes is controversial because of concerns about cost-effectiveness.

OBJECTIVE:

To evaluate the cost-effectiveness of ECG plus cardiovascular-focused history and physical examination compared with cardiovascular-focused history and physical examination alone for preparticipation screening.

DESIGN:

Decision-analysis, cost-effectiveness model.

DATA SOURCES:

Published epidemiologic and preparticipation screening data, vital statistics, and other publicly available data.

TARGET POPULATION:

Competitive athletes in high school and college aged 14 to 22 years.

TIME HORIZON:

Lifetime.

PERSPECTIVE:

Societal.

INTERVENTION:

Nonparticipation in competitive athletic activity and disease-specific treatment for identified athletes with heart disease.

OUTCOME MEASURE:

Incremental health care cost per life-year gained.

RESULTS OF BASE-CASE ANALYSIS:

Addition of ECG to preparticipation screening saves 2.06 life-years per 1000 athletes at an incremental total cost of $89 per athlete and yields a cost-effectiveness ratio of $42 900 per life-year saved (95% CI, $21 200 to $71 300 per life-year saved) compared with cardiovascular-focused history and physical examination alone. Compared with no screening, ECG plus cardiovascular-focused history and physical examination saves 2.6 life-years per 1000 athletes screened and costs $199 per athlete, yielding a cost-effectiveness ratio of $76 100 per life-year saved ($62 400 to $130 000).

RESULTS OF SENSITIVITY ANALYSIS:

Results are sensitive to the relative risk reduction associated with nonparticipation and the cost of initial screening.

LIMITATIONS:

Effectiveness data are derived from 1 major European study. Patterns of causes of sudden death may vary among countries.

CONCLUSION:

Screening young athletes with 12-lead ECG plus cardiovascular-focused history and physical examination may be cost-effective.

PRIMARY FUNDING SOURCE:

Stanford Cardiovascular Institute and the Breetwor Foundation.

Comment in

PMID:
20194233
[PubMed - indexed for MEDLINE]
PMCID:
PMC2873148
Free PMC Article

Images from this publication.See all images (3)Free text

Figure 1
Figure 2
Figure 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Silverchair Information Systems Icon for PubMed Central
    Loading ...
    Write to the Help Desk